Regulation 21 Outline consent

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

reg. 21(1) words omitted by National Health Service (Pharmaceutical Services) 2004 reg. 14
reg. 21(1) words substituted by National Health Service Reform and Health Care Professions Act 2002 (Supplementary, Consequential etc. Provisions) 2002 reg. 13 Sch. 10
reg. 21(1) words substituted by National Health Service (Local Pharmaceutical Services Etc.) 2002 reg. 15 Sch.

(1)

A doctor wishing to be granted the right to provide pharmaceutical services under regulation 20 by arrangement with an FHSA to patients residing in an area, may apply to the FHSA in writing for consent (in these Regulations referred to as “outline consent”) specifying the area in relation to which he wishes the outline consent to be granted.

(2)

An application under paragraph (1) shall be determined in accordance with regulation 12.

(3)

An outline consent shall have effect from its final grant but shall cease to have effect where either—

(a)

no arrangement under regulation 20 has been made pursuant to it within 12 months from its final grant; or

(b)

more than 12 months elapses after the last provision of drugs and appliances under an arrangement made pursuant to it.